Avid Bioservices Depreciation And Amortization Over Time
| CDMO Stock | USD 12.30 0.05 0.41% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Avid Bioservices Performance and Avid Bioservices Correlation. Avid |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (2.29) | Revenue Per Share 2.245 | Quarterly Revenue Growth 0.065 | Return On Assets (0.03) |
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avid Bioservices' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Depreciation And Amortization Analysis
Compare Avid Bioservices and related stocks such as Anebulo Pharmaceuticals, Adagene, and Acrivon Therapeutics, Depreciation And Amortization Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANEB | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 3.6 M | 6.8 M | 11.8 K | 258.3 K | 245.4 K |
| ADAG | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 858.4 K | 1.1 M | 1.4 M | 1.2 M | 1.3 M |
| ACRV | 13 K | 13 K | 13 K | 13 K | 13 K | 13 K | 13 K | 13 K | 13 K | 13 K | 13 K | 832 K | 364 K | 536 K | 479.9 K |
| ANAB | 580 K | 580 K | 580 K | 580 K | 308 K | 274 K | 233 K | 183 K | 315 K | 11 M | 559 K | 2.1 M | 2.3 M | 2.4 M | 2 M |
| MLYS | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 18.7 M | 228.5 K | 167.9 K | 159.5 K |
| CRNX | 92 K | 92 K | 92 K | 92 K | 92 K | 92 K | 92 K | 128 K | 471 K | 887 K | 948 K | 922 K | 983 K | 1.1 M | 760.2 K |
| CYTK | 2.8 M | 1.3 M | 591 K | 433 K | 490 K | 589 K | 741 K | 1.9 M | 1.2 M | 5.8 M | 1.8 M | 9.6 M | 8.4 M | 11.9 M | 12.5 M |
| BCYC | 332 K | 332 K | 332 K | 332 K | 332 K | 332 K | 332 K | 332 K | 712 K | 960 K | 1.3 M | 1.4 M | 3.7 M | 6.5 M | 6.9 M |
| IMCR | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 6.7 M | 10.6 M | 9 M | 7.6 M | 5.3 M | 4.1 M | 5.8 M |
| MIRM | 324 K | 324 K | 324 K | 324 K | 324 K | 324 K | 324 K | 324 K | 324 K | 324 K | 623 K | 975 K | 3.7 M | 10.8 M | 11.4 M |
| LRMR | 70 K | 70 K | 70 K | 70 K | 70 K | 70 K | 212 K | 188 K | 261 K | 78 K | 155 K | 326 K | 318 K | 311 K | 234.5 K |
| KALV | 38 K | 38 K | 38 K | 27 K | 38 K | 33 K | 40 K | 180 K | 378 K | 879 K | 651 K | 743 K | 802 K | 816 K | 424 K |
| LYRA | 82 K | 82 K | 82 K | 82 K | 82 K | 82 K | 82 K | 82 K | 82 K | 27 K | 95 K | 1 M | 1.1 M | 278 K | 467.5 K |
| EWTX | 123 K | 123 K | 123 K | 123 K | 123 K | 123 K | 123 K | 123 K | 123 K | 123 K | 185 K | 272 K | 538 K | 1.6 M | 1.6 M |
| DYN | 333 M | 346 M | 26 M | 467 M | 292 M | 614 M | 766 M | 867 M | 24 K | (762 K) | 700 K | 1.1 M | 1.7 M | 1.7 M | 1.6 M |
| IDYA | 391 K | 391 K | 391 K | 391 K | 391 K | 391 K | 391 K | 391 K | 886 K | 1.2 M | 1.4 M | 1.7 M | 2.1 M | 4 M | 4.2 M |
| MGTX | 243.1 K | 243.1 K | 243.1 K | 243.1 K | 243.1 K | 243.1 K | 243.1 K | 679.2 K | 2.1 M | 3.3 M | 4.2 M | 7.9 M | 8.7 M | 13.7 M | 14.4 M |
| KROS | 304 K | 304 K | 304 K | 304 K | 304 K | 304 K | 304 K | 304 K | 304 K | 438 K | 605 K | 898 K | 1.6 M | 815 K | 857.1 K |
Avid Bioservices and related stocks such as Anebulo Pharmaceuticals, Adagene, and Acrivon Therapeutics, Depreciation And Amortization description
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.My Equities
My Current Equities and Potential Positions
| Avid Bioservices | CDMO |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 12.3
Check out Avid Bioservices Performance and Avid Bioservices Correlation. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Avid Bioservices technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.